Solid Tumor Clinical Trials
A listing of Solid Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 1109 clinical trials
Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors
TQB3915 is a selective estrogen receptor covalent antagonist, by covalently binding to estrogen receptor, by changing the conformation of ERα, blocking intracellular signal transmission, thereby inhibiting the growth of tumor cells.
- 0 views
- 29 Jun, 2022
- 1 location
A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors
Nivolumab in participants with select advanced solid tumors.
- 0 views
- 30 Jun, 2022
- 3 locations
Study of Oral Debio 0123 in Combination With Carboplatin in Participants With Advanced Solid Tumors
The primary objective of the study is to determine the recommended phase 2 dose (RP2D) of Debio 0123 when administered in combination with carboplatin in participants with advanced solid tumors
- 16 views
- 12 Jul, 2022
- 4 locations
Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors
activity profile of the RP2D of OBI-999 in patients with advanced solid tumors.
- 0 views
- 21 Jul, 2022
- 4 locations
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors (WEE1)
A Phase 1 Dose Escalation and Expansion Study of IMP7068 Monotherapy in Advanced Solid Tumors
- 0 views
- 21 Jul, 2022
- 14 locations
A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors
The purpose of this study is to determine the recommended phase 2 dose (RP2D) regimen(s) of JNJ-78306358 in Part 1 (Dose Escalation) and to determine the safety of JNJ-78306358 at the RP2D regimen(s) in Part 2 (Dose Expansion).
- 0 views
- 23 Jul, 2022
- 5 locations
Safety, Tolerability, and Pharmacokinetics of CAL056 Mesylate in Patients With Resistant or Refractory Solid Tumors
cancer patients with resistant or refractory solid tumors.
- 7 views
- 23 Jul, 2022
- 3 locations
REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors (COMBINE-EGFR-1)
patients with advanced solid tumors Dose Expansion: • To assess the preliminary efficacy of REGN7075 in combination with cemiplimab within selected advanced solid tumor-specific cohorts, as
- 6 views
- 21 Jul, 2022
- 8 locations
Dose Escalation and Expansion Study of SAR444200 in Adult Participants With Advanced Solid Tumors
This is a single group, treatment, Phase 1/Phase 2, open label, multiple cohort, first-in-human study to evaluate safety and efficacy of SAR444200 as a monotherapy or in combination with other anti-cancer agents for participants aged at least 18 years with previously treated metastatic malignancies.
- 0 views
- 29 Jul, 2022
- 1 location
Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid Tumors
This is a phase I, multicenter, open-label dose escalation and expansion study to evaluate genakumab alone and in combination with tislelizumab in adult patients with advanced solid malignancies.
- 0 views
- 28 Jul, 2022
- 1 location